--- title: "Dragon and Tiger List | DEZHAN HEALTHCARE (000813) hit the limit down, with the top 5 sell orders totaling 116 million yuan. Reason for being listed: The top 5 securities with a daily amplitude of 15%" type: "News" locale: "en" url: "https://longbridge.com/en/news/287201536.md" description: "DEZHAN HEALTHCARE (000813) fell to the daily limit on May 21, closing at 3.81 yuan, with a circulating market value of 7.989 billion yuan. Data from the Dragon and Tiger List shows that the buying amount was 65.9296 million yuan, the selling amount was 116 million yuan, and the net buying amount was -50.5073 million yuan. The top five buying seats collectively bought 61.0557 million yuan, while the top five selling seats collectively sold 116 million yuan. The operating revenue for 2024 is expected to be 466 million yuan, with a net profit of -20 million yuan. The operating revenue for the first half of 2025 is estimated to be 166 million yuan, with a net profit of -43 million yuan" datetime: "2026-05-21T10:31:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287201536.md) - [en](https://longbridge.com/en/news/287201536.md) - [zh-HK](https://longbridge.com/zh-HK/news/287201536.md) --- # Dragon and Tiger List | DEZHAN HEALTHCARE (000813) hit the limit down, with the top 5 sell orders totaling 116 million yuan. Reason for being listed: The top 5 securities with a daily amplitude of 15% According to Tongbi Finance, on May 21, DEZHAN HEALTHCARE (000813) appeared on the stock market's leaderboard. Reason for listing: this stock was among the top 5 securities with a daily volatility of 15%. The buying amount on the leaderboard was CNY 65.9296 million, the selling amount was CNY 116 million, and the net buying amount was -CNY 50.5073 million. The top 5 buying amounts totaled CNY 61.0557 million. Among them, the first buying position was from Dongfang Securities Co., Ltd. Shanghai Songjiang District Huting North Road Securities Business Department, buying CNY 17.0854 million; the second buying position was from Guotai Junan Securities Co., Ltd. Ruian Xinyang Avenue Securities Business Department, buying CNY 16.3082 million; the third buying position was a special account for Shenzhen Stock Connect, buying CNY 11.3992 million; the fourth buying position was an institutional special account, buying CNY 10.1684 million; the fifth buying position was from Huashan Securities Co., Ltd. Changsha Furong Middle Road Securities Business Department, buying CNY 6.0945 million. The top 5 selling amounts totaled CNY 116 million. Among them, the first selling position was a special account for Shenzhen Stock Connect, selling CNY 46.2872 million; the second selling position was from GF Securities Co., Ltd. Zhuhai Doumen Zhu Feng Ke Chuang Center Securities Business Department, selling CNY 24.3347 million; the third selling position was from Soochow Securities Co., Ltd. Suzhou Wuzhong District Mudu Town Securities Business Department, selling CNY 20.0271 million; the fourth selling position was an institutional special account, selling CNY 13.0466 million; the fifth selling position was an institutional special account, selling CNY 12.3985 million. As of the close on May 21, DEZHAN HEALTHCARE (000813) hit the daily limit down, closing at CNY 3.81, with a circulating market value of CNY 7.989 billion and a turnover rate of 7.03%. _Tongbi Finance Tip:_ _DEZHAN HEALTHCARE (000813.SZ) reported an operating income of CNY 466 million for 2024, with a revenue growth rate of -6.34%. The net profit attributable to the parent company was -CNY 20 million, with a net profit growth rate of -124.50%, and a return on equity of -0.39%._ _In the first half of 2025, the company's operating income was CNY 166 million, with a revenue growth rate of -33.01%. The net profit attributable to the parent company was -CNY 43 million, with a net profit growth rate of -522.81%._ _Currently, the company belongs to the healthcare industry, primarily engaged in pharmaceutical distribution. In the 2024 annual report, the main composition of its business was pharmaceutical sales: 99.43%; others: 0.56%; material sales: 0.01%._ ### Related Stocks - [000813.CN](https://longbridge.com/en/quote/000813.CN.md) - [600958.CN](https://longbridge.com/en/quote/600958.CN.md) - [03958.HK](https://longbridge.com/en/quote/03958.HK.md) - [600909.CN](https://longbridge.com/en/quote/600909.CN.md) - [000776.CN](https://longbridge.com/en/quote/000776.CN.md) - [01776.HK](https://longbridge.com/en/quote/01776.HK.md) - [601555.CN](https://longbridge.com/en/quote/601555.CN.md) ## Related News & Research - [Green Cross Health Brings Forward AGM to Combine With Medical Division Sale Vote](https://longbridge.com/en/news/290640370.md) - [Faster food, drugs, lithium, on the way](https://longbridge.com/en/news/290617205.md) - [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/290572738.md) - [Equinox Partners holds 90,133,518 Japan Gold shares, 29.32% stake](https://longbridge.com/en/news/290548385.md) - [11:07 ETDigital Health Tools Are Reshaping Healthcare in the United States](https://longbridge.com/en/news/290454782.md)